Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease.

Sachiko I. Blaber, Bogoljub Ciric, George P. Christophi, Matthew J. Bernett, Michael Blaber, Moses Rodriguez, Isobel A. Scarisbrick

Research output: Contribution to journalArticlepeer-review

89 Scopus citations

Fingerprint

Dive into the research topics of 'Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease.'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds